Skip to main content

and
  1. Article

    Open Access

    Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis

    Anaplastic lymphoma kinase (ALK) fusion-positive colorectal cancer (CRC) is a rare and chemotherapy-refractory subtype that lacks established and effective treatment strategies. Additionally, the efficacy and ...

    Zi-**g Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo in npj Precision Oncology (2024)